Opened TUBE VTAE AVNR

A busy day as there were a number of setups I really liked.

Tube
A recent IPO that has had an orderly pul l back and a great breakout.  Now it appears that the back test was successful and when selling looked to be ending I took a position as it went positive
Entry $15.09

VTAE
A recent IPO that has shown some power. After checking down and retesting it went higher. This one has good potential.
Entry:
$13.70 ,  I bought higher that I would like. For that reason I didn't put a lot of size on .  I still think it makes a run towards 17 and for that reason I was willing to pay up for it.

AVNR

This is the move I was waiting for out of this pattern.  A great Bull Flag that was wrapping around higher like AGIO did before it burst out.  In at 13.01  

Stopped out of HYGS-- Lessons in narrowly missing a great trade.

Arrgh!  I was absolutely right on this reversal but my stop just got nicked before It took off.

Stopped at 14.89.  -- The absolute low of the day.

The next day +1.91 it would go as high as 17.50 within another 2.

Entry: $16.04

Exit: $14.89  - $1.15 .9R

Summary

There are a few ways I can choose to feel about this trade.  At one time I may have felt regret or chose to put a wider stop in taken more risk etc...  I could take pride in that I was right about the reversal.  But pride is not a consolation prize when money is lost.

Here is what I now assess this trade.  I used the wrong setup.  I was thinking that this would behave like the big % movers that  the fishhook set up works so well on.   So I got my fishhook entry signal and took it (causing me to buy high) I didn't put a ton of size so I could enjoy a wide stop.

What I see now is that a big% move out of a down trend is not appropriate for a Fishhook.  Rather it is a trend termination signal. This means I should have waited for the consolidation (i.e. RWLK) and bought the range expansion. Had I done so this would have worked beautiful.  As it turns out, it's a lesson learned.

Closed RWLK. 22.37% Winner.

In a month filled with a lot of big winners. This one has been the biggest.  This was a buy one day sell the next morning trade.  I know from past trading that RWLK has a tendency to fade the day after a big move.  So I got my gap and I sold into the strength $31.73.  So I missed the fade throughout the remainder of the day.

Entry: 25.93
Exit: 31.73  +5.80  +22.37%  +6.6R

Summary

This trade worked well because my buy was an A+.  I bought it while the days trading range was s still a very tight doji after 4 progressively smaller down days.  Because the trading range was so tight, I was able to put decent size on the trade and only take a small risk .25R.  When you see that type of action after a move it frequently signals a that the sell off is ending and momentum is coming back into the market.  I sold RWLK high because I am familiar with this stock and could see that it made very few multi-day bullish moves.  The ones it makes are powerful, which is why I felt comfortable buying.

2017 -- Note:
In retrospect, I would no longer consider this a A+  setup or trade.  As An Ipo, this had not setup above opening range push, which means its a pull back setup, in a medical device stock, which tend not to perform well as IPOS. ..

As it turned out, I bought a position in a low float stock that got a push and then sold close to what would be the highs of this stock:

TWTR attempted bounce trade.

TWTR got smoked after earnings.  It looked Like it might bounce into the gap as a number of stocks had done.  I took a shot.

Entry 44.72
Exit.  44.33   - .39 .  .4R   Worth a shot.  Good risk management on the trade it didn't work. I kept tight risk parameters which saved me from a much larger loss.

Fast forward 3 days and I see how much pain I potentially avoided:

Closed VIPS

This turned out to be a nice little trade.  I could have taken profits higher but I wanted to give it some room to run as it had done so for the past few days.  I kept moving my stop up, but once it was clear that this would close red today, I decided just to take the profits.  My entry was decent but not good enough to give it enough room to pull back without risk taking a loss. If I were riding it from 180, I might think differently but it is what it is-- a decent 1% profit. 

Entry: 204.75

Exit. 211.05 3.07% +1R

Opened RWLK-- Love it when this happens

RWLK looked like it was going to have a very quiet day.  I thought I would try a breakout anticipation type trade as it was in a very tight range after trading down the last 4.  Some of the other recent IPOs like CYBER were having strong days, so I figured why not, because of the tightness of the range I was able to put some nice size into this trade.   Shortly after I entered, this exploded for a huge day.

Entry: $25.93

We'll see what tomorrow brings.

XIV mean reversion Trade

On Friday I opened up XIV after it reversed. I've done well in XIV so I thought I would take another shot.  This time it went for a b/e trade as it started to fade pre-market.  Since I have not elected mark-to-market accounting, I thought it best to preserve the gain and my ability to trade it over the next 31 days. 

Entry: 31.73

Exit: 31.88

Opened and closed: JAKK -- Joke was on me

I was traveling but JAKK was on my watch list.  It had everything-- Nice Consolidation, good earnings, improved guidance, a small float and a allegedly huge short ratio.  At a minimum this was a nice momo burst set up, but I had Big Gain Hunting on my mind as  ESI, which put up a 250% move after beating expectations with a high short ratio.   I bought pre-market. (painfully high) and then added and added again.  I then came to my senses and puked it out.

Entry 1: $9.50 

Entry 2:  $8.94 

Entry 3. $7.51 

avg. $8.93

Exit: $7.23

-2.45R

There's a lot to talk about here.  First, I let my expectations override the price action.  When this trade  started to fade I should have gotten completely out.  Waiting for a bounce on a losing position is a recipe for disaster.   Second, I'm guessing that there was a lot of shorts exiting their positions well before earnings.  We had a great V shaped recovery that would force a lot of short covering.  Since short ratio's lag, I think its a fair bet that the ratio was not nearly as high as reported.  That being said, I think bulls flooded into this trade with expectations of a squeeze and when it never materialized we got destroyed. 

From my own trade, I was horrible here.  I was traveling so I gave it more time than I should have,  I then added as it went against me.  I deserved this loss. 

Opened VIPS

VIPS has been a very strong stock and it had a nice V shapped recovery I bought as we had a range expansion day Entry 204.79

Facing the Music, Stopped out P

Stopped out of P at 23.24. -.65R

Entry: 22.22

This looked like it was about to roll over but yesterdays action was pretty strong taking it through the  13MA.  That continued throughout the mooring as this went as high as 23.67.  Earnings are tomorrow.  I would not have held through earnings unless I had a gain to work with.  

BlackHawk Down Stopped Out HAWK

It took just a  day, but HAWK broke the other way. I got stopped out at 32.99. 

Why didn't this trade work?  

For me it's a case of seeing what i wanted to see.  I had some primacy bias as I just had a big winner in AGIO so I saw the parts of that setup in HAWK. Would I have taken HAWK otherwise at that point, probably not. I  jumped the pattern in HAWK. It's a setup that works but it usually needs at least 15 days before its ready. HAWK was only 9 days in and the first b/o attempt failed. Also there is a gap from 32 to 33 that called out to be filled as angle of the price action trended towards that gap like a magnet.

Fortunately, I kept the loss small enough  -.65R to avoid damaging my equity balance.

New Swings- HYGS, HAWK

I bought HYGS today in a fishhook type trade- it also would trigger on the Elder Impulse . Given the strength of the V shaped recovery I thought this is worth a try.  Here's what I see.  A break of the pace of the down trend with a successful  back test. This is somewhat of a fishhook entry as the strong move held.  in at 16.06 Stop 15. 87.

HAWK:
I like this set up as it weathered the downtrend much better than most stocks and now it is flagging.  I've found that buying within the consolidation can be a decent low risk entry.  However, it might need to trade sideways for another couple of days.  It just hit the 13, so it may get a kick but I think its more likely to get its burst when it hits the 20.

BABA Daytrade

Of the setups I went through this morning BABA and TWTR looked the best.  TWTR had a downgrade so I looked to BABA.  I loved this set up as the day before had a very tight range. It was trading up slightly pre-market futures were up and all the leaders were catching a bid.  I entered pre-market at $88.80.  It broke 90 and then went off to the races.  I sold out at $91.57 after it ran to 92.50 and started selling off.

Entry: 88.80

Exit. 91.57 (+2.77)

1.34R

Closed AGIO 1 day 9.64% gains.

My swing trade from yesterday broke out in a big way:

I sold out for several reasons I continue to be skeptical of market action so I've taken profits quickly.  Perhaps too quickly, perhaps not.   My previous C.A. trade in PANW had a similar pattern and impressive breakout only to fail the next day.

I had only planned on selling half but I got nervous as it came in more. So with that in mind, I exit with a very nice profit

Entry: 65.75
Exit 1: 72.09 (+ $6.34, 9.64%)  1152
Exit 2: 71.51  (+$5.76, 8.76)
+ 4R

Open Swing Trades: AGIO, P.

I opened up two swing trades today: one long, one short.

AGIO.  This is a Chart I've been watching for a week or so now.  It has that great flag after running up.  The market pull back did not touch it.  Although it's previous breakout out attempt failed. I felt that this on was A go.  Bought 65.75, Stop 63.75.  Multi-day moves have been rare these days  Continuation Anticipation trades but this looks as good as any.  I just wish it had more volume.

P: This is what I look for in a short.  A solid down trend.  The 13 MA is tracking it well which means the selling is relatively quick.  Then a bounce back up which initially fails. I took this at the end of the day @22.22  stop at 23.05

DAY TRADES, INO, SCOK, APPL, XIV

I don't like day trading but some days the just trades present themselves.  I don't trust the market right now to take Lottery Ticket type trades over night.  So I've gotten out of trades quickly  I had one bad trade today,  quite frankly it was unacceptable.  But  I still closed out 5 day trades and 1 trade from Friday for a 1R% gain on my equity.

SCOK 

Some news on SCOK a gap with some volume.  Based on past history and a small float I figured this would be in play.

I bought at $3.80, It ran up to 4.20.  Rather than sell there I wanted to give it a chance to run so I moved my stop up to 3.95.  It got hit on the next pull back.

After seeing it run to a high of 4.44, I thought I would give it another chance hoping that it would have some magic left for power hour.  It was not to be.  This got a bit away from me as it slid. I added more in hopes of a pop but I got stopped on the whole position.

Trade 1:
Entry 3.80
Exit 3.95
+.15, +3.9%,  +.34R

Trade 2:
Entry 4.23, 3.85 (avg. 4.04)
Exit. 3.68
1.17R - 8.9% .  I let my knowledge of Scok's past run cloud my judgment.  I had visions of a 5 handle close in my mind and it cost me.

IBIO

I liked the strength of this going into the close on Friday.  Apparently  there was a negative Seeking Alpha article and this gapped down.  As it bounced up it set a range in the 2.40s.  I wanted to see what it could do once it hit the gap.  I bought in at 2.46 (anticipate the break of 2.50) it worked very well.  The stock eventually faded pretty hard.  Why did I sell?  I guess it's because I didn't really trust the Ebola rally and would rather sell on the way up.

Summary 
Entry: 2.46
Exit: 2.74  (11.4%) + .9 R

Not bad for 20 minutes. My take away from this trade is keep an eye on the stocks that closed strong the day before.  Even if they gap the other way there may be a profitable trade hiding in there.  This had a nice tightening up and then it burst.

XIV
I caught another great bounce in the XIV.
Entry: 29.77
Exit : 30.49
.72, 2.5% .5R
I decided to sell on the close as the market has now put in a nice rally heading towards a V shaped recovery.  I'm looking for some selling to come in over the next day or so and I want to preserve equity.  I don't feel that this is the place to establish a long term position, so I would rather do the quick hits.

AAPL
AAPL beat earnings today.  I picked it up A.h. at 100.20  it traded up gradually but  there did not seem to be a lot of panic to get into positions.  For that reason, I felt it was best to bang it out before the morning.  out 101.05  .85, .8%, .27R

Closed OBCI

OBCI sold off again. Rather than attempting to hold out for the last dollar I decided to close it out as the volume dried up.  There are now better opportunities out there. 

Trade summary:

Entry:  4.46

Exit: $4.14 (+7.17%)

.26R -- I wasn't able to get filled with the size I had hoped so this round turned out to be a rather uneventful 7% move.  

Reflections on One Crazy Week--5 day return 13.2% YTD: 53.81

Wow! We had a hugely volatile week: 

We had Ebola, We had melt downs, rallies.  I traded fast and furious and had my best week of the year-13.20%.  On a trade by trade basis, I probably had more losers than winners which is rare but I made my winners count.  Mean reversion was the name of the game.  XIV, HCLP.   But close behind was Ebola fever as I had trades in VRS and APT that saw a total of 20 minutes during regular trading.  After hours is great when stocks run to the A.M.

As I reflect on this week, I think my success is owed to the fact that I did not trust a single trade I made.  I had no problem getting out of trades as they were still going up.  I may have not hit homers but I hit a lot of doubles and triples that are rare in normal market trading conditions.

Any way here's the states:

This week looks great on my YTD returns as I close the week at my highest levels of the year.  Not too bad considering the overall market conditions.  My breakouts have had only marginal success since July.  

I need to be careful and lighten up off the gas.  All my biggest drawdowns, have come after my account has hit new highs and I thought I could bend my trading plans and rules.  To that end, I end the week with a beer and an account that is 95% in cash. Cheers.

Opened OBCI- short round 2.

A few people have come to believe that OBCI is an ebola play because it now owns a disinfectant called performacide -- which it purchased 2 weeks ago for a mere $150,000.

I previously shorted this stock successfully from 5.30 to 3.95.  I was very pleased to see it bounces again on low volume, which allowed me to take another shot at it.  I was able to get a tranche filled of my short @ 4.47.  I had orders to short more, which did not get filled as this stock couldn't get a bit higher. 

A weekly chart really demonstrates how extraordinary this recent "ebola" move has been in relation to obci's trading history.


This has set up nice for a pop and drop rather than an "EP":

• Sustainability of New Demand, revenue and earnings?   

Stocks like LAKE and APT have products that fill a demand that is currently unfilled.  There will be a shortage of hazmat suits, etc..   .  Yet every hospital, restaurant, airport, and most homes already have products that are more than capable of killing Ebola.  All you need is a commercial grade disinfectant  there are hundreds of products that fill that need.  But don't take my word for it, per the CDC: 

"Ebola is killed with hospital-grade disinfectants (such as household bleach)"

Heck, just in my basement, I already own at least 3 cleaners which I've owned for years that could kill Ebola: 

Odorban :

• OdoBan® is an EPA registered disinfectant. The EPA Registration No. is 66243-2.
• OdoBan® meets AOAC efficacy standards for hospital disinfectants.
• OdoBan® meets AOAC efficacy standards for non-food contact surface sanitizers on hard non-porous surfaces.
• OdoBan® is a Hospital Disinfectant Cleaner that is effective against a wide variety of Gram positive and Gram negative bacteria. It is also an excellent deodorant and leaves a clean fresh odor. Respiratory illnesses attributable to Pandemic 2009 H1N1 are caused by influenza A virus. OdoBan® is a broad-spectrum hard surface disinfectant that has been shown to be effective against Influenza A/Hong Kong and is expected to inactivate all influenza A viruses including Pandemic 2009 H1N1 (formerly called swine flu). OdoBan® has demonstrated effectiveness against Influenza A/Hong Kong and is expected to inactivate all influenza A viruses including Pandemic 2009 H1N1 (formerly called swine flu)

Simple Green D (my wife likes organic shit) but again it would serve the same purpose

• Hospital–grade disinfectant
• One–step cleaner and deodorizer
• Fresh herbal–pine scent
• High dilution ratios for great economy

Ideal for airplanes, airports, athletic facilities, cafeterias, clinics, day care centers, emergency vehicles, exercise facilities, food service facilities, hospitals, hotels and motels, kitchens, locker rooms, nursing homes, prisons and correctional facilities, public restrooms, schools and colleges, anywhere cleanliness and disinfection are necessary.

Clorox Bleach.  Perhaps  most significant regular, ordinary bleach will kill ebola.  No body needs to turn to some cleaner they've never heard off out of fear, They can go to the products they already buy such as Clorox Bleach, which is more than capable of killing ebola.  

In fact, the company has already donated 12,000 bottles  of Bleach to fight ebola: 

"This week our company took a first step, donating 12,000 64-ounce bottles of Clorox® bleach destined for West Africa. " 

Incidentally, Clorox's initial donation has a market value of nearly the entirety of OBCI's purchase of performacide. 

Consequently, I would question whether there will be any uptick in profits at all.  Any revenue OBCI receives would be mere fraction of the purchase price it paid for Performacide.  Obviously, if performacide were generating 150K in profits a year, it would have sold for a multiple of its earnings (P/e ratio).

• But isn't Performacide the best, Ebola killer out there?

Anyone that makes such a claim has obviously not read the specs for Performacide.  

"Solution will be usable in 60 minutes (1 hour).
NOTE: Allow ONE (1) HOUR BEFORE USE TO ENSURE SOLUTION REACHES FULL STRENGTH. Be sure to agitate upon addition of the pouch to the water and before initial use. Temperature must be kept between 20-25oC. "

So we have an Ebola outbreak and I have to choose how to clean it up.  Do I go with the product such as bleach that can be used immediately or do I pick Performacide which I have to wait an hour to use?

• Soft goods, such as linens, clothes, etc..? nope:  Performacide is a "DISINFECTANT OR VIRUCIDE* FOR HARD, NON-POROUS SURFACES? 

• Buyout potential

I've seen bulls now make the claim that this is a "buy out candidate"  because it has tight insider ownership.  I can't tell you how many times, I've heard such claims by bulls (usually with losing positions that are holding out hope of getting even) that xyz is a buyout candidate.  Anyway, here is why that will not happen.  

Entities that buy companies are typically not stupid. They are not going to pay an "Ebola" premium for a company such as OBCI that has not demonstrated any revenue acceleration, but has shown stagnate revenue growth over the past few years:

Another reason I do not see a buyout is that the company insiders rely heavily inn the company for income.  In addition to their salaries there are a number of "Related Party Transactions" that   app are to make more for the insiders than their OBCI day jobs: 

Per the 10-Q

• During the three and six months ended June 30, 2014 and 2013, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. 
• Sales to the affiliated companies aggregated approximately $295,000 and $469,000 during the three months ended June 30, 2014 and 2013, respectively, and approximately $1,008,000 and $940,000 for the six months ended June 30, 2014 and 2013, respectively. 
• This begs the question why is the CEO's personal companies distributing OBCI's products instead of OBCI?   

• "the terms of sale to the affiliated companies differed from the terms applicable to other customers ..."  OBCI then goes on to attempt to justify the sweet heart deal the CEO's affiliate company is getting  "the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges" 

And there's more:

• "A subsidiary of the Company currently uses the services of an entity that is owned by its Chairman, President and Chief Executive Officer to conduct product research and development, marketing and advertising. .. the Company paid the entity approximately $10,500 for each of the three month periods ended June 30, 2014 and 2013, and $21,000 for each of the six month periods ended June 30, 2014 and 2013."

• The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.  

•  A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis.  During the three months ended June 30, 2014 and 2013, the Company paid an aggregate of approximately $98,000 and $150,000, respectively, and during the six months ended June 30, 2014 and 2013, the Company paid an aggregate of approximately $315,000 and $333,000, respectively, in insurance premiums on policies obtained through the entity. 

These types of transaction should always raise red flags. Frankly, If I were a shareholder I would question the property of such transactions. If these deals are worth doing, why isn't management doing them for the company instead of for themselves.  Got fiduciary duty? Well at least we know  that management would be insured against such a claim from the policies they purchased from their director's company. 

I've worked with numerous private equity groups.  There is no way that investors are going to buyout a company that has all these additional contracts to benefit management's own companies.  I would also suspect that management has no interest in selling given the deals their own companies are making off the backs of the OBCI shareholders. 

Q2 results that saw EPS growth of 137% doesn't that demonstrate huge growth?    not so much turns out.  ---  Consider Q1 Revs.  Down pretty big.  

So what happened?  Well it turns out that Q1 was pretty cold in most parts of the country and customers delayed their purchases that they would have made in Q1 to Q2-- so Q1 looked horrible and Q2 looked amazing.  Combine q1 and q2  them Q13 had 14.49 mill versus 14.72 mill in revs for Q1.  Not exactly setting the world on fire with that type of growth.  

Summary

• Stock price has increased purely on Ebola hype
• OBCI is unlikely to ever realize any revenues due to that hype
• A buyout is a pipe dream of desperate longs. 
• Current earnings and rev growth do not support the stock price pop
• Price target-- Back to business as usual. $2.95-3.25

ESI DT

I kick myself. This was mentioned yesterday as an EP.   I nearly got in pre-market at 5.30 but was watching some other positions.  My hesitation cost me a 100% move in 20 Minutes.

ESI came from an absolute annihilation from 47 to 3 YTD.  That's neglect,  It has over a 50% short float and the earnings and subscribers numbers came back better than expected. This had massive volume coming in and I have no doubt this will be in play for days. 

Anyway, after missing the opening move, I thought I could overcome  my failure to take an initial position by taking a smaller position with a wider stop.  It did't work out:

Summary:

Entry: $ 9.98

Exit: $8.92

-.67R ,    (Should have waited for the Fishhook entry rather than chase)

Closed XIV, Mean Reversion Trade

As I had hoped, the rally put in another + day.  My XIV trade did very well.  I exited as I saw the russell rally faltering.  Divergence suggests this rally will fail.  I had hoped for 32 but I'd rather sell well when everyone is still giddy.

Entry: 25.22
Exit: 28.75 (14%)
+ 2.9R  This turned out to be a very nice little swing trade

CLOSED: ANR

This bottom was not to be as it gave its gains from yesterday back.  When it did so, my premises failed.  So I'm out
Entry: 2.34
Exit: 2.00
- 2.5R.   A big loss.  Remind my self to be more patient.  There's no need to be a hero by picking a bottom in Coal absent massive volume.

New Position ANR

This is a turn around play I've tracked and waited and waited for some time.  Finally I saw something That made it worth getting in.  I nice big move on high volume.   Stop @ 2. 3R, which is big for me (rules are met to be broken sometimes as I normally will only go to 2R)  That being said, I believe in this set up and put enough size to make this an amazing trade if it works. 

I want to see a similar move to the steel stocks.    300 -400% 

Opened XIV

Market looked good moving of lows in the A.M. I thought I would see if this would play.  Gapped down and I bought 25.22  Nice rally to a high of 27.74.  I moved my stop up to 26.05.

Target 33.

Closed HCLP

When mean reversion trades work, they really work.  HCLP Really worked.  No need to press my luck here.  This was the largest move this particular stock has ever made.  

Entry:  44.88

Exit 1: 45.68 (1/2) (+.80, 1.7%) 1

Exit 2: 50.53 (1/2) (+5.65,  13%)

+2.15R --- and with that I pass the 50% mark  on the year!

closing remarks 

What I did well on this one is I kept stalking it.  Earlier this week when it faded, I got out with a small profit.  I saw it set up again and hit it again.  

Taking partial profits  I don't necessarily trust bounces in this market.  They have been very profitable because I don't trust them.  By taking partial profits, I moved my stop to a point where I could let the remainder run and still end up with a profitable trade.   

Why Did I sell?

The overall trend of this stock is still down.  As much as I would like to think that HCLP bounces right back to the highs there is too much damage.  I initially targeted the 200MA (48.40) as the profit target for this trade. Obviously, I got more than that and am pleased.  I'll let the rest of the traders play the rest of the bounce.  If it sets up again, perhaps I'll play along. 

Trade Summaries VSR, CERS, MAR, HCLP, XIV, LEAF, DGLY, APT, Closing in on 50%

It's been a couple of crazy, busy, and profitable days.  I've put risk on took risk off played MOMO and Mean Reversion Trades.   I'm trading very cautiously with reckless abandon.  By that I mean I am taking a lot of shots but if they are not working I'm getting out very quickly. Given the number of trades I've taken I'm doing a bulk update.

Tuesday:
Closed VSR -Pre-market  6.13.  There was a Seeking Alpha hit piece, The ebola trade is getting crowded and at some point it will end in dramatic fashion.  I believe in booking profits and this one went for over 3R without a single minute of exposure to regular market hours, which would have been subject to a brutal pull back.

Entry: 4.20
Exit 1: 5.50  (31%)
Exit 2: 6.13  (46%)

CERS:
This had some momentum behind it and I had hoped it would continue.  It seemed to get stuck, so I bailed.

Entry: 4.26
Exit 1: 4.18
Exit: 2. 4.05
- .04R

DGLY
This former momo beast started to show some renewed energy on a new patent and a new order. I though this move and news might prompt something bigger.  I took a small starter position. Not to be it dropped hard.

Entry: 11.94
Exit: 11.05
- .04R

HCLP:
A blast from the past. Could it be bottoming?  Bought 44.88  seemed to be fading.  Do I trust this market? Nope
Entry: 44.88
Exit 1: 45.61
Exit 2: 45.22  +141
+.25R

LEAF:
So the markets fading but my LEAF trade has somehow miraculously not only held up after nearly being stopped ( I was probably down 1.5R with a 2R stop,)  it gained that all back and somehow I'm green on the position.  Market volatility is increasing.  I decided to cut my position size for a small gain:

Entry: 33.75
Exit 1 (partial): 33.86

MAR
So this one is in a waterfall.  It started to make a comeback, I didn't see it with the ebola thing going around.  Who wants to fly these days?  If no one flies hotels suffer.

Entry: 62.72  (target 60)
Stop. 63.75

Opened VSR ... Big Gain Hunting.

Another Ebola Play.  They have a subsidiary--VersarPPS- that makes biohazard suits--, decontaimnation rooms etc and all sorts of protective containment equipment.  Their equipment is already used in Ebola hot zones  and they have donated suits to the cause. 

I Bought A.H. 4.20.  Sold off half at $5.50 as this has taken off.  Just over 9 Mill shares outstanding so this is going to get a lot of play.

As fun as VSR is I could see it running. It has a book value of 3.15 with $1.00 in cash in the bank. Trading at .32 times sales as of close.   This could Triple and still be cheap. 

OBCI Short. An odor removal for Homeless Shelters becomes a Ebola Momo play

OBCI a company that makes a Chlorine Dioxiode disinfectant and is capable (like hundreds  of other products) Lysol or bleach of killing viruses.  It ran on Ebola Fever.  I shorted it at 5.33, it then proceeded to fall:

To suggest that this is an ebola play shows a total lack of due diligence.  They bought Performacide for 150K two weeks ago.   The active ingredient in Performacide is chlorine Dioxide.  Chornine Dioxide is a chlorine substitute, which was discovered in 1814. It has been used since 1944 to kill pathogens.

Anyway, OBCI bought out its partrner for 150K and now has the rights to the Performacide name.Just last year Performacide was being market to residential cleaning and odor removal applications... and to homeless shelters:

"INTENDED USERSHospitality and rental property owners and managers, maintenance and housekeeping personnel, house renovators, home owners, fishermen, hunters, homeless shelters, and anyone with mold or organic odors to eliminate.

Now its true that Chlorine dioxide can kill viruses. As can bleach. Nonetheless, OBCI puts out a misleading press release that suggests that the CDC approved its product to kill Ebola:

"The CDC recommendations include use of a U.S. Environmental Protection Agency (EPA) registered hospital disinfectant with a label claim on non-enveloped viruses (such as norovirus, rotovirus, adenovirus and poliovirus) for surfaces in rooms of patients with suspected or confirmed Ebola virus infection." 

Yes, the CDC does recommend using Disinfectants where Ebola --or any other viruses has been suspected or confirmed.  The CDC's actual comments were as follows:  

"Although there are no products with specific label claims against the Ebola virus, enveloped viruses such as Ebola are susceptible to a broad range of hospital disinfectants used to disinfect hard, non-porous surfaces. In contrast, non-enveloped viruses are more resistant to disinfectants. As a precaution, selection of a disinfectant product with a higher potency than what is normally required for an enveloped virus is being recommended at this time. EPA-registered hospital disinfectants with label claims against non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus) are broadly antiviral and capable of inactivating both enveloped and non-enveloped viruses."

OBCI's press release continues: 

 "The EPA has accepted labeling for Performacide^® claiming effectiveness as, among other things, a viruscide against the non-enveloped viruses referred to above, as well as other viruses, and a disinfectant against a number of different types of bacteria."

Yes, Performacide is a virusicde which the EPA lists as approved --on page 65 of 65-- along with 800 other products.  In other words, there are hundreds of competing products for disinfectant uses. Nonetheless,  some people have interpreted OBCI's press release as stating that OBCI was THE company the CDC and the EPA approved to fight ebola.  OBCI's website is telling.  They make products for boats, jet skies, law mowers. Nothing that exactly says we are at the forefront of disease prevention